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Abstract
An indirect fluorescent antibody (IFA) procedure was developed for the detection of Cryptosporidium sp.
oocysts in human, nonhuman primate, and bovine fecal smears. The procedure, which takes about 90 min
to perform, involves the use of a rabbit antiserum against Cryptosporidium oocysts isolated from dairy
cattle. Cross-specificity testing of the IFA method revealed no reactivity with yeasts, various amoebae,
Giardia lamblia, Chilomastix sp., or Blastocystis sp. and only very weak cross-reactivity with coccidian
oocysts of other genera. IFA detection of oocysts in human and nonhuman primate fecal smears was far
more sensitive than was dimethyl sulfoxide-carbolfuchsin staining. Moreover, IFA detection was
comparable in sensitivity to auramine O staining with samples of high oocyst concentration and
somewhat more sensitive than auramine O with samples containing relatively few oocysts. The IFA
procedure may be useful in the clinical diagnosis of human and animal cryptosporidiosis and also in the
detection of oocysts in environmental samples.
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An indirect fluorescent antibody (IFA) procedure was developed for the detection of Cryptosporidium sp.
oocysts in human, nonhuman primate, and bovine fecal smears. The procedure, which takes about 90 min to
perform, involves the use of a rabbit antiserum against Cryptosporidium oocysts isolated from dairy cattle.
Cross-specificity testing of the IFA method revealed no reactivity with yeasts, various amoebae, Giardia
lamblia, Chilomastix sp., or Blastocystis sp. and only very weak cross-reactivity with coccidian oocysts of other
genera. IFA detection of oocysts in human and nonhuman primate fecal smears was far more sensitive than was
dimethyl sulfoxide-carbolfuchsin staining. Moreover, IFA detection was comparable in sensitivity to auramine
O staining with samples of high oocyst concentration and somewhat more sensitive than auramine 0 with
samples containing relatively few oocysts. The IFA procedure may be useful in the clinical diagnosis of human
and animal cryptosporidiosis and also in the detection of oocysts in environmental samples.

Cryptosporidium sp. is a coccidian parasite of humans and
animals and an agent of acute enterocolitis (9, 24, 34). Cases
of human infection involving the respiratory tract have also
been reported (19, 23). Although formerly believed to be
strictly a zoonosis, cryptosporidiosis is now believed to be
acquired also through person-to-person transmission (2, 3, 6,
8). The prevalence of detectable Cryptosporidium infection
in the human population as a whole is very low-probably
below 1%-although no survey of the general population has
ever been published. However, in patients with gastrointestinal symptoms the prevalence of infection has been reported
to range from 1.2 to 9% in developed countries (12, 14, 16,
17, 25, 33; D. P. Casemore, M. Armstrong, and B. Jackson,
Letter, Lancet i:734-735, 1984; D. P. Casemore and B.
Jackson, Letter, Lancet ii:679, 1983) and from 4 to 13% in
developing countries (4, 20, 21, 28, 35; N. Hojlyng, K.
Molbak, S. Jepsen, and A. P. Hansson, Letter, Lancet i:734,
1984). A number of reports have shown that the prevalence
of infection is generally higher in children than in adults (4,
6, 16, 25, 28, 33; Casemore et al., Letter, 1984; Casemore
and Jackson, Letter, 1983) and also higher among children in
urban areas than in rural areas (20; Hojlyng et al., Letter,
1984). A number of outbreaks of cryptosporidiosis were
reported recently in day-care centers in the United States (7,
32). In patients with acquired immunodeficiency syndrome
or other immunodeficient or immunodepressed states,
Cryptosporidium infection is a serious complication and may
result in a life-threatening loss of fluids and electrolytes (8,
18, 22, 29, 36).
Cryptosporidium infection is diagnosed by identifying the
oocyst stage of the parasite in host feces or biopsy tissue.
Oocysts are most commonly identified in clinical laboratories by acid-fast staining of fecal smears or concentrates with
carbolfuchsin (cold Kinyoun stain, dimethyl sulfoxide
[DMSO]-carbolfuchsin, or Ziehl-Neelsen stain) (5, 11, 13,
18, 19, 23), by fluorescence staining with auramine-phenol
(11, 25, 32, 35; Casemore et al., Letter, 1984; G. Nichols and
B. T. Thom, Letter, Lancet i:735, 1984), or by oocyst
flotation on Sheather sucrose solution followed by phase
*

microscopy (10, 18). Other effective methods of oocyst
detection are also used, including safranin staining (4, 21; D.
Baxby and N. Blundell, Letter, Lancet ii:1149, 1983), iodine
staining (18), Hemacolor staining (19), methylene blue-eosin
staining (26), Giemsa staining (20, 33), negative staining by
periodic acid-Schiff reagent (15), and electron microscopy
(1). The use of combinations of some of the above methods
of oocyst detection is commonly reported. Garcia et al. (11)
compared 15 methods of oocyst detection and concluded
that a modified (hot) Ziehl-Neelsen staining of 10% Formalin-preserved stool is superior to all other methods tried
(safranin was not tested). Bronsdon (5) reported that the
DMSO-carbolfuchsin staining method was only slightly less
sensitive than auramine staining in detecting oocysts in stool
smears; auramine seemed more sensitive for detecting
oocysts in smears containing very few oocysts. Ma and
Soave (18) recommend a three-step stool examination
method for diagnosing cryptosporidiosis, involving an iodine-stained wet mount followed by Kinyoun acid-fast staining and cover slip flotation of oocysts in Sheather sucrose.
Ma and Soave also conclude that Sheather sucrose flotation
is more effective at concentrating oocysts than is Formalinether sedimentation.
Fluorescent antibody (FA) detection is another potentially
specific and sensitive way of visualizing Cryptosporidium
oocysts in fecal smears or concentrates. An FA method
tends to have the advantage of high sensitivity, provided that
the parasite antigens are stable in stool preparations and that
cross-reaction with other organisms does not occur. Sterling
and colleagues (30, 31) recently showed that the detection of
Cryptosporidium oocysts in fecal smears by direct immunofluorescence with a monoclonal antibody is a practical and
specific method of diagnosis, although some cross-reactivity
was obtained with certain fecal yeasts. An FA detection
method has also been reported for the detection of Giardia
lamblia cysts in fecal smears (27).
By using a rabbit antiserum prepared against Cryptosporidium oocysts of bovine origin, we tested the sensitivity
and specificity of an indirect FA (IFA) method of detecting
Cryptosporidium oocysts in fecal smears of human, nonhuman primate, and bovine origin and quantitatively compared
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the sensitivity of this method to that of the auramine and
DMSO-carbolfuchsin staining techniques.
MATERIALS AND METHODS
The oocysts used in the preparation of rabbit antiserum
were isolated from the manure of Holstein calves (7 to 15
days old) which had previously been confirmed as
Cryptosporidium infected by DMSO-carbolfuchsin staining
(5) of fecal smears. Cattle herds from which manure specimens were obtained were located in the valleys of the
Snoqualmie, Skykomish, and Snohomish rivers, approximately 30 miles east by northeast of Seattle, Wash. The
oocysts were purified by the following steps: (i) removal of
crude particles from manure by filtering an aqueous suspension of manure through several layers of gauze or cheesecloth; (ii) vacuum filtration through brass soil sieves (diameter, 54 mm; pore sizes, 0.5 mm and 125 pLm); (iii) passing the
filtrate obtained as described above through a 400-mesh
nylon net (pore size, 50 ,um); (iv) centrifuging the filtrate at
500 x g for 5 min; (v) washing the sediment three times with
distilled water; (vi) suspending the pellet in distilled water
and extracting fats, etc., up to five times by shaking the
suspension for 30 s with an approximately 1/10 volume of
ethyl acetate, centrifuging after each extraction for 5 min at
500 x g (the extracted material was discarded); (vii) floating
the oocysts present in the sediment on Sheather sucrose
solution (see reference 18 for details); (viii) washing the
recovered oocysts three times with distilled water; and (ix)
centrifuging the oocysts for 15 min at approximately 650 x g
over a step-gradient of Percoll (Sigma Chemical Co., St.
Louis, Mo.) in water (layers of specific gravity 1.13, 1.09,
1.05, and 1.01) prepared in a 12-ml conical centrifuge tube,
followed by removal of the oocyst band from above the 1.09
and 1.13 layers and washing of the oocysts three times with
distilled water. After step v, the oocysts were usually
suspended and stored in 1% Formalin in phosphate-buffered
saline (PBS; pH 7.6) to prevent losses from possible excystation of oocysts and bacterial or fungal overgrowth. The use
of rhodamine-albumin (Difco Laboratories, Detroit, Mich.)
counterstain in immunofluorescence tests (see below) later
revealed that these oocyst preparations were virtually free of
yeasts but did contain a small amount of unidentified enteric
bacilli. Purification beyond this point was not attempted.
Antioocyst serum was prepared in two adult New Zealand
white rabbits by initial intradermal inoculation, at multiple
sites, of oocysts mixed 1:1 with Freund complete adjuvant (3
x 106 oocysts per rabbit) followed by intramuscular booster
inoculations of 2 x 106 to 5 x 106 oocysts per rabbit in
incomplete Freund adjuvant at 3, 6, and 8 weeks after the
initial inoculation. The rabbits were bled by cardiac puncture
under methoxyflurane anesthesia 5 days after the last
booster injection. The serum was stored at -20°C.
Human, nonhuman primate, and bovine fecal specimens
for IFA testing were obtained from the following sources. A
monkey fecal specimen containing low numbers of
Cryptosporidilum oocysts was obtained from a formula-fed,
orphaned infant pig-tailed macaque (Macaca nemestrina)
through the courtesy of Melinda Bronsdon of the Regional
Primate Center, University of Washington, Seattle. This
specimen had been stored at 4°C for 8 days before use. A
human-source specimen containing Cryptosporidiiiium
oocysts was obtained through the courtesy of Carolyn Wallis
of the Clinical Microbiology Laboratory, Harborview Medical Center, Seattle, Wash., and was stored in 2.5% potassium dichromate for 6 weeks at 4°C before use. This sample
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then washed twice with distilled water, pelleted by
centrifugation, and suspended in distilled water immediately
before use. This specimen was used in the quantitative
comparison of oocyst detection methods. Another
Cryptosporidiuon-positive human stool specimen was obtained through the courtesy of Sam Eng of the Clinical
Microbiology Laboratory, University Hospital, Seattle,
Wash., and used within 1 day of collection without dilution
in potassium dichromate. Bovine-source Cryptosporidiumpositive fecal specimens were obtained from Holstein calves
as described above and stored for less than 1 week before
use. Thin smears of each of the above specimens were
prepared on alcohol-cleaned microscope slides (1 by 3 in.
[2.54 by 6.62 cm]) by using a cotton-tipped applicator.
Staining of the fecal smears was performed in the following manner. DMSO-carbolfuchsin (acid-fast) staining was
done by the method of Bronsdon (5), except that staining
with the carbolfuchsin was done for 5 min and staining with
the counterstain was done for 2 min. The slides were flamed
momentarily before being fixed in the methanol. Prepared

was

solutions of the DMSO-carbolfuchsin and the malachite
green counterstain were obtained from Prepared Media
Laboratories, Tualatin, Oreg. These reagents had been previously found to give excellent staining results with
Cryptosporidiirn oocysts in fecal smears. Staining with
auramine 0-phenol was done by briefly heat-fixing the
smeared slides and then immersing the slides in 0.1%
auramine 0 in 9.5% ethanol-3% phenol for 15 min. After
being destained for 2 min in a solution of 0.5% HCI-70%
ethanol, the slides were rinsed briefly with tap water and
counterstained in 0.5% aqueous potassium permanganate for
3 min. The slides were then briefly rinsed with tap water and
air dried. Auramine 0 powder was obtained from Sigma.
The immunofluorescence staining procedure was done as
follows. The fecal smears were air dried and then fixed in
acetone for 5 min. Acetone-fixed slides were stored until use
at -20°C in airtight plastic slide boxes containing desiccant.
At the time of use, the smears were flooded with immune
rabbit anti-Ciyptosporidiuim serum or with preimmune serum diluted 1:40 with PBS (pH 7.6) and incubated in a humid
chamber at 37°C for 30 min. Afterward, the slides were
rinsed three times, 5 min per rinse, in PBS and air dried.
Fluorescein-conjugated goat anti-rabbit immunoglobulin G
antiserum (anti-heavy and -light chains; Cooper Biomedical,
Inc., Malvern, Pa.) was then applied to the slides at a 1:40
dilution in PBS, and the slides were incubated as before.
Rhodamine-albumin counterstain (Difco) was sometimes included at a 1:80 dilution with the conjugated second antiserum. After three final rinses in PBS, the slides were air
dried and mounted with a cover glass (25 by 60 mm) and a
mounting medium consisting of 90% glycerol in PBS with
p-phenylenediamine at 0.1 mg/ml. The IFA slides were
examined at x400 magnification with a fluorescence microscope (Carl Zeiss Inc., Thornwood, N.Y.) with epiillumination. Photos were taken at x 190 magnification on
Ektachrome 160 tungsten slide film (Eastman Kodak Co.,

Rochester, N.Y.).

The relative sensitivity of the three methods of oocyst
staining was determined by using smears made from both the
monkey fecal specimen and the dichromate-preserved human fecal specimen. With each specimen, 15 thin, uniform
fecal smears were prepared on alcohol-cleaned microscope
slides by using either a second slide (human specimen) or a
cotton-tipped applicator (monkey specimen) for smearing.
The cotton-tipped applicator was used for the monkey
specimen because the stool was formed and thick in consis-
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FIG. 1. Cryptosporidium oocysts, purified from cattle feces, on
the surface of a polycarbonate filter (pore size, 1.0 [rm; Nuclepore
Corp., Pleasanton, Calif.), as revealed by indirect immunofluorescence. Arrow indicates oocyst. Bar = 10 ,um.

tency. Five slides of each specimen were prepared for
staining by each method. The number of oocysts on each
slide was determined by counting the oocysts visible per
field in 27 fields (human specimen) or 150 fields (monkey
specimen) examined per slide under x400 magnification.
Bright-field microscopy was used for the carbolfuchsinstained slides; epifluorescence microscopy was used for the
auramine- and IFA-stained slides. The fields counted on
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each slide were divided evenly among the left, middle, and
right thirds of the slide area. Differences between the mean
numbers of oocysts counted per slide by each staining
method were compared statistically by using a one-tailed
Student t test.
RESULTS
The antioocyst immune serum bound strongly and specifically to purified Cryptosporidiium oocysts of bovine origin
by indirect immunofluorescence (Fig. 1). Strong reactions
were obtained at antiserum dilutions of 1:20, 1:40, and 1:60.
At a 1:80 dilution, fluorescence decreased noticeably but
was still apparent. Preimmune rabbit serum showed no
reaction with oocysts (data not shown). Fluorescence obtained by using the immune serum emanated primarily from
the walls of the oocysts. No binding of antiserum to internal
components was observed. Binding of antiserum to excysted
sporozoites was not tested. Immunofluorescence tests also
revealed that the purified bovine-source oocysts used in
immunization contained small numbers of bacilli. These
bacteria did not bind antiserum but were revealed by the
rhodamine counterstain.
The immunofluorescence procedure clearly detected
Cryptosporidium oocysts in human, monkey, and bovine
fecal smears (Fig. 2). The human fecal specimen shown in
Fig. 2A was the one not stored in potassium dichromate.
Cryptosporidium oocysts were virtually the only objects in
the fecal smears that were bound by the antiserum. The
oocysts observed in all samples were of uniform size (3 to 5
,m in diameter), indicating that the species was probably
Cryptosporidium parvum in each specimen (34).
Immunofluorescence cross-reactivity testing (with the
same dilutions of primary and secondary antisera as noted
above) revealed no binding of the antioocyst immune serum
to cultured Candida albicans yeasts; to human-source G.
lamblia, Entamoeba histolytica, Entamoeba coli, or
Endolimax nana cysts; to Giardia sp., Chilomastix sp., and
Entamnoeba sp. cysts isolated from a muskrat (Ondatra
zibethica); to Blastocystis hominis cells from a human stool

FIG. 2. Cryptosporidium oocysts visualized by immunofluorescence in fecal smears of human (A), monkey (B), and cattle (C) origin.
Arrows indicate oocysts. Bars = 10 p.m.
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TABLE 1. Comparison of the sensitivity of IFA,
DMSO-carbolfuchsin, and auramine methods in detecting

Cryptosporidium oocysts
Source and
method

x Oocysts/slide

Oocyst count
SD"

pb

Human feces
IFA
Auramine
DMSOcarbolfuchsin

210.0
204.6
15.6

24.9
35.9
8.3

NS"
<0.005

Monkey feces
IFA
Auramine
DMSOcarbolfuchsin

21.6
8.8
4.0

5.8
4.6
2.8

<0.005
<0.0005

aStandard deviation of the oocyst counts per slide.
b From Student's t test one-tailed comparison of mean oocyst counts per
slide with mean counts obtained by IFA method; differences considered
significant if P < 0.05.
C NS, Not significant at the 95% confidence level.

specimen; or to yeast cells obtained directly from the small
intestine of a laboratory mouse. However, weak-positive
immunofluorescence did result with Eimeria sp. oocysts
derived from cattle (provided by Richard Wescott, Washington State University, Pullman) and with Caryospora sp.
oocysts derived from a timber rattlesnake (provided by
Donald D. Smith, University of Kansas Medical Center,
Kansas City).
With both of the fecal specimens used in the sensitivity
comparison of the staining methods, the IFA method was
much superior to DMSO-carbolfuchsin staining (Table 1).
With the human-derived specimen, IFA and auramine gave
similar results and were not statistically different in sensitivity. However, with the monkey fecal specimen, in which
oocysts were very sparse, the IFA method detected more
than twice as many oocysts per slide as the auramine method
did. The IFA method detected more than 13 times as many
oocysts as did the carbolfuchsin method with the human
specimen and more than five times as many with the monkey
specimen. Auramine 0 was also 13 times more sensitive than
carbolfuchsin with the human specimen (P < 0.005) and was
more than twice as sensitive with the monkey specimen (P <
0.05). These differences were all statistically significant at or
above the 95% confidence level.
DISCUSSION
Indirect immunofluorescence is clearly a sensitive and
specific method for detecting Cryptosporidium oocysts in
fecal smears from human and animal sources. The IFA
method was substantially more sensitive in oocyst detection
than was the DMSO-carbolfuchsin method of staining. The
IFA method yielded results comparable to those of the
auramine staining method in smears with high oocyst concentrations and was significantly (P < 0.005) more sensitive
in smears with low oocyst concentrations.
The IFA method has an obvious advantage in sensitivity
over the DMSO-carbolfuchsin staining method. However, it
also has several disadvantages. Like the auramine method, it
requires the use of a fluorescence microscope, an instrument
that is not available in all clinical laboratories. Two other
drawbacks of the IFA method are (i) the time (approximately
90 min) needed to perform the test and (ii) the lack of a
commercially available antiserum against Cryptosporidium

oocysts. The use of a direct immunofluorescence method of
oocyst staining, employing antiserum conjugated directly to
fluorescein, would shorten the procedural time considerably,
perhaps to as little as 15 min, by eliminating the requirement
for a second incubation. The development of monoclonal
antibodies specific for Cryptosporidium oocysts, as reported
recently by Sterling et al. (30, 31), would eliminate the need
for laborious production of polyclonal antiserum and thus
should facilitate the clinical application of immunofluorescence detection methods. However, cross-reactivity of
monoclonal antibodies with fecal yeasts (as reported by
Sterling and colleagues [30, 31]) or potentially with other
organisms underscores the importance of extensive testing
of the species specificity of antibody reagents and thorough
documentation of any consistent patterns of cross-reactivity.
The cysts of most other parasitic protozoa are considerably larger than Cryptosporidium oocysts and generally
possess characteristic anatomical features that allow rapid
identification. Thus, FA methods for the identification of
these other, larger protozoan cysts would probably not
represent a significant improvement over current identification methods. Cryptosporidium oocysts, however, are small
enough to be easily confused with yeasts or small Blastocystis cells unless special staining methods are used. In our
experience, carbolfuchsin failed to stain some of the oocysts
in a fecal specimen. Other researchers have reported similar
observations (4, 35; Casemore et al., Letter, 1984; Nichols
and Thom, Letter, 1984). Iodine or Giemsa staining, negative staining by periodic acid-Schiff reagent, and examination of unstained preparations floated on Sheather sucrose
all seem to allow for some error or confusion on the part of
inexperienced persons. In contrast, the IFA and auramine
methods of oocyst staining are two of the most sensitive,
specific, and foolproof methods available for oocyst detection. Because of its greater sensitivity, particularly for
smears with low oocyst concentrations, the immunofluorescence method would seem to be the detection method of
choice in studies on the prevalence of Cryptosporidium
infection in human or animal populations. Additional applications of immunofluorescence detection of oocysts lie in the
fields of environmental microbiology, environmental engineering, and municipal water and wastewater treatment, in
which the technique can be used to detect and quantify
Cryptosporidium oocysts in municipal water supply sources
(J. E. Ongerth and H. H. Stibbs, submitted for publication).
In summary, the indirect immunofluorescence method described here represents a useful new technique for
Cryptosporidium identification.
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